Merck & Co., Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
Merck & Co., Inc. (MRK) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 2.33 million shares for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-24.
Discontinued › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2023-02-24
- Merck & Co., Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2019-12-31 was -204.00K shares, a 139.23% decline year-over-year.
- Merck & Co., Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2019-09-30 was 0.00 shares.
- Merck & Co., Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2018-12-31 was 520.00K shares, a 124.14% increase year-over-year.
- Merck & Co., Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2018-09-30 was 0.00 shares.
- Merck & Co., Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2022 was 2.33M shares, a 51.35% decline from fiscal 2021.
- Merck & Co., Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2021 was 4.78M shares, a 34.15% increase from fiscal 2020.
- Merck & Co., Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2020 was 3.56M shares, a 27.47% increase from fiscal 2019.
- Merck & Co., Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2019 was 2.80M shares, a 20.57% decline from fiscal 2018.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month |
|---|---|---|---|---|---|
| 2022-12-31 | 2.33M shares 10-K · filed 2023-02-24 | ||||
| 2021-12-31 | 4.78M shares 10-K · filed 2022-02-25 | ||||
| 2020-12-31 | 3.56M shares 10-K · filed 2021-02-25 | ||||
| 2019-12-31 | -204.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | -204.00K shares derived: sum of 2 quarters · filed 2020-02-26 | 2.80M shares 10-K · filed 2020-02-26 | ||
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | 3.00M shares 10-Q · filed 2019-11-05 | |||
| 2019-06-30 | 3.00M shares 10-Q · filed 2019-08-06 | ||||
| 2018-12-31 | 520.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | 520.00K shares derived: sum of 2 quarters · filed 2019-11-05 | 3.47M shares derived: sum of 3 quarters · filed 2019-11-05 | 3.52M shares 10-K · filed 2019-02-27 | |
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | 2.95M shares derived: sum of 2 quarters · filed 2019-11-05 | 3.00M shares 10-Q · filed 2019-11-05 | 3.23M shares derived: sum of 4 quarters · filed 2019-11-05 | |
| 2018-06-30 | 2.95M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | 3.00M shares 10-Q · filed 2019-08-06 | 3.23M shares derived: sum of 3 quarters · filed 2019-08-06 | 3.23M shares derived: sum of 4 quarters · filed 2019-08-06 | |
| 2018-03-31 | 46.00K shares 10-Q · filed 2019-05-08 | 278.00K shares derived: sum of 2 quarters · filed 2019-05-08 | 278.00K shares derived: sum of 3 quarters · filed 2019-05-08 | 4.09M shares derived: sum of 4 quarters · filed 2019-05-08 | |
| 2017-12-31 | 232.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | 232.00K shares derived: sum of 2 quarters · filed 2018-11-06 | 4.04M shares derived: sum of 3 quarters · filed 2018-11-06 | 4.23M shares 10-K · filed 2018-02-27 | |
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | 3.81M shares derived: sum of 2 quarters · filed 2018-11-06 | 4.00M shares 10-Q · filed 2018-11-06 | 4.22M shares derived: sum of 4 quarters · filed 2018-11-06 | |
| 2017-06-30 | 3.81M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | 4.00M shares 10-Q · filed 2018-08-07 | 4.22M shares derived: sum of 3 quarters · filed 2018-08-07 | 4.22M shares derived: sum of 4 quarters · filed 2018-08-07 | |
| 2017-03-31 | 190.00K shares 10-Q · filed 2018-05-08 | 410.00K shares derived: sum of 2 quarters · filed 2018-05-08 | 410.00K shares derived: sum of 3 quarters · filed 2018-05-08 | 6.34M shares derived: sum of 4 quarters · filed 2018-05-08 | |
| 2016-12-31 | 220.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | 220.00K shares derived: sum of 2 quarters · filed 2017-11-07 | 6.15M shares derived: sum of 3 quarters · filed 2017-11-07 | 6.22M shares 10-K · filed 2017-02-28 | |
| 2016-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | 5.93M shares derived: sum of 2 quarters · filed 2017-11-07 | 6.00M shares 10-Q · filed 2017-11-07 | 6.57M shares derived: sum of 4 quarters · filed 2017-11-07 | |
| 2016-06-30 | 5.93M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | 6.00M shares 10-Q · filed 2017-08-08 | 6.57M shares derived: sum of 3 quarters · filed 2017-08-08 | 6.57M shares derived: sum of 4 quarters · filed 2017-08-08 | |
| 2016-03-31 | 74.00K shares 10-Q · filed 2017-05-09 | 639.00K shares derived: sum of 2 quarters · filed 2017-05-09 | 639.00K shares derived: sum of 3 quarters · filed 2017-05-09 | 5.54M shares derived: sum of 4 quarters · filed 2017-05-09 | |
| 2015-12-31 | 565.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | 565.00K shares derived: sum of 2 quarters · filed 2016-11-07 | 5.47M shares derived: sum of 3 quarters · filed 2016-11-07 | 5.57M shares 10-K · filed 2016-02-26 | |
| 2015-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | 4.91M shares derived: sum of 2 quarters · filed 2016-11-07 | 5.00M shares 10-Q · filed 2016-11-07 | 4.87M shares derived: sum of 4 quarters · filed 2016-11-07 | |
| 2015-06-30 | 4.91M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | 5.00M shares 10-Q · filed 2016-08-08 | 4.87M shares derived: sum of 3 quarters · filed 2016-08-08 | 4.87M shares derived: sum of 4 quarters · filed 2016-08-08 | |
| 2015-03-31 | 95.00K shares 10-Q · filed 2016-05-09 | -33.00K shares derived: sum of 2 quarters · filed 2016-05-09 | -33.00K shares derived: sum of 3 quarters · filed 2016-05-09 | 4.89M shares derived: sum of 4 quarters · filed 2016-05-09 | |
| 2014-12-31 | -128.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | -128.00K shares derived: sum of 2 quarters · filed 2015-11-05 | 4.79M shares derived: sum of 3 quarters · filed 2015-11-05 | 4.87M shares 10-K · filed 2015-02-27 | |
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | 4.92M shares derived: sum of 2 quarters · filed 2015-11-05 | 5.00M shares 10-Q · filed 2015-11-05 | 4.70M shares derived: sum of 4 quarters · filed 2015-11-05 | |
| 2014-06-30 | 4.92M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | 5.00M shares 10-Q · filed 2015-08-06 | 4.70M shares derived: sum of 3 quarters · filed 2015-08-06 | 4.70M shares derived: sum of 4 quarters · filed 2015-08-06 | |
| 2014-03-31 | 80.00K shares 10-Q · filed 2015-05-07 | -217.00K shares derived: sum of 2 quarters · filed 2015-05-07 | -217.00K shares derived: sum of 3 quarters · filed 2015-05-07 | ||
| 2013-12-31 | -297.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | -297.00K shares derived: sum of 2 quarters · filed 2014-11-10 | 5.70M shares 10-K · filed 2014-02-27 | ||
| 2013-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | 6.00M shares 10-Q · filed 2014-11-10 | |||
| 2013-06-30 | 6.00M shares 10-Q · filed 2014-08-07 | ||||
| 2012-12-31 | 641.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | 641.00K shares derived: sum of 2 quarters · filed 2013-11-07 | 7.62M shares derived: sum of 3 quarters · filed 2013-11-07 | 7.64M shares 10-K · filed 2013-02-28 | |
| 2012-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | 6.98M shares derived: sum of 2 quarters · filed 2013-11-07 | 7.00M shares 10-Q · filed 2013-11-07 | 7.21M shares derived: sum of 4 quarters · filed 2013-11-07 | |
| 2012-06-30 | 6.98M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | 7.00M shares 10-Q · filed 2013-08-07 | 7.21M shares derived: sum of 3 quarters · filed 2013-08-07 | 7.21M shares derived: sum of 4 quarters · filed 2013-08-07 | |
| 2012-03-31 | 19.00K shares 10-Q · filed 2013-05-09 | 228.00K shares derived: sum of 2 quarters · filed 2013-05-09 | 228.00K shares derived: sum of 3 quarters · filed 2013-05-09 | 8.20M shares derived: sum of 4 quarters · filed 2013-05-09 | |
| 2011-12-31 | 209.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | 209.00K shares derived: sum of 2 quarters · filed 2012-11-09 | 8.18M shares derived: sum of 3 quarters · filed 2012-11-09 | 8.21M shares 10-K · filed 2012-02-28 | |
| 2011-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | 7.97M shares derived: sum of 2 quarters · filed 2012-11-09 | 8.00M shares 10-Q · filed 2012-11-09 | 8.51M shares derived: sum of 4 quarters · filed 2012-11-09 | |
| 2011-06-30 | 7.97M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | 8.00M shares 10-Q · filed 2012-08-07 | 8.51M shares derived: sum of 3 quarters · filed 2012-08-07 | 8.51M shares derived: sum of 4 quarters · filed 2012-08-07 | |
| 2011-03-31 | 25.00K shares 10-Q · filed 2012-05-08 | 533.00K shares derived: sum of 2 quarters · filed 2012-05-08 | 533.00K shares derived: sum of 3 quarters · filed 2012-05-08 | 6.23M shares derived: sum of 4 quarters · filed 2012-05-08 | |
| 2010-12-31 | 508.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | 508.00K shares derived: sum of 2 quarters · filed 2011-11-08 | 6.21M shares derived: sum of 3 quarters · filed 2011-11-08 | 7.51M shares 10-K · filed 2011-02-28 | |
| 2010-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | 5.70M shares derived: sum of 2 quarters · filed 2011-11-08 | 7.00M shares 10-Q · filed 2011-11-08 | 7.40M shares 10-Q · filed 2010-11-08 | |
| 2010-06-30 | 5.70M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | 7.00M shares 10-Q · filed 2011-08-08 | |||
| 2010-03-31 | 1.30M shares 10-Q · filed 2011-05-09 | ||||
| 2009-09-30 | 1.10M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | 33.00M shares 10-Q · filed 2010-11-08 | |||
| 2009-06-30 | 31.90M shares 10-Q · filed 2010-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |